Literature DB >> 2900130

Effects of alpha-adrenoceptor blockers on renal function and blood pressure adjustment in human hypertension.

G Leonetti1.   

Abstract

In this paper the different aspects of the role played by alpha-adrenoceptors in the control of renin secretion from the juxtaglomerular apparatus and renal sodium and water reabsorption, and the effects of alpha-adrenoceptor antagonists on systemic haemodynamics, will be investigated. Animal experiments suggest that the renal alpha-adrenoceptors exert a restraining action on renin secretion while increasing tubular reabsorption of sodium and water. A recent study in man has confirmed the alpha-adrenoceptor-mediated inhibition of renin secretion. Previously available ganglion blocking and antiadrenergic agents, while causing a significant supine blood pressure reduction, can cause at the same time clinically relevant side effects such as orthostatic hypotension, sedation, drowsiness etc. The advent of selective alpha 1-adrenoceptor blockers, such as prazosin and urapidil, allow a significant blood pressure reduction without significant interference on haemodynamic adjustments and only induce a limited incidence of side effects.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2900130     DOI: 10.2165/00003495-198800356-00007

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  6 in total

1.  Prazosin: the first-dose phenomenon.

Authors:  R M Graham; I R Thornell; J M Gain; C Bagnoli; H F Oates; G S Stokes
Journal:  Br Med J       Date:  1976-11-27

2.  Renal adrenoceptor mediation of antinatriuretic and renin secretion responses to low frequency renal nerve stimulation in the dog.

Authors:  J L Osborn; H Holdaas; M D Thames; G F DiBona
Journal:  Circ Res       Date:  1983-09       Impact factor: 17.367

3.  Comparison of the antihypertensive effect of urapidil and metoprolol in hypertension.

Authors:  G Leonetti; C Mazzola; S Boni; E Guffanti; A Meani; A Zanchetti
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

4.  Prazosin does not alter levels of plasma lipids, glucose, and insulin.

Authors:  F Cambien; P F Plouin
Journal:  J Cardiovasc Pharmacol       Date:  1985 May-Jun       Impact factor: 3.105

5.  Dissociation of the effects of alpha 1-adrenergic blockade on blood pressure and renin release in patients with essential hypertension.

Authors:  A Morganti; C Sala; A Palermo; L Turolo; A Zanchetti; J Laragh
Journal:  J Cardiovasc Pharmacol       Date:  1982       Impact factor: 3.105

6.  Interactions between the sympathetic nervous system and the kidney: experimental observations.

Authors:  A Stella; A Zanchetti
Journal:  J Hypertens Suppl       Date:  1985-12
  6 in total
  2 in total

1.  Biochemical effects of urapidil on red cell membrane ion transport systems in a population of elderly essential hypertensives.

Authors:  R Antonicelli; E Balducci; G Lipponi; C Lucantoni; R Gaetti; E Paciaroni
Journal:  Postgrad Med J       Date:  1991-03       Impact factor: 2.401

Review 2.  Drug treatment of hypertension.

Authors:  B N Prichard
Journal:  Drugs       Date:  1988       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.